1001. Hazekamp MG, Schoof PH, Suys BE, et al. Switch back: using the pulmonary autograft to replace the aortic valve after arterial switch operation.
J Thorac Cardiovasc Surg 1997; 114: 844-846.
1002. Imamura M, Drummond-Webb JJ, McCarthy JF, et al. Aortic valve repair after arterial switch operation. Ann Thorac Surg 2000; 69: 607-608.
1003. Vricella LA, Williams JA, Ravekes WJ, et al. Early experience with valve-sparing aortic root replacement in children. Ann Thorac Surg 2005; 80: 1622-
1626.
1004. Spiegelenberg SR, Hutter PA, van de Wal HJ, et al. Late reinterventions following arterial switch operations in transposition of the great arteries.
Incidence and surgical treatment of postoperative pulmonary stenosis. Eur J Cardiothorac Surg 1995; 9: 7-10.
1005. Nogi S, McCrindle BW, Boutin C, et al. Fate of the neopulmonary valve after the arterial switch operation in neonates. J Thorac Cardiovasc Surg
1998; 115: 557-562.
1006. Hovels-Gurich HH, Seghaye MC, Ma Q, et al. Long-term results of cardiac and general health status in children after neonatal arterial switch
operation. Ann Thorac Surg 2003; 75: 935-943.
1007. Williams WG, Quaegebeur JM, Kirklin JW, et al. Outflow obs t ruct ion af ter the ar ter ial swi tch operat ion: a multiinstitutional study. Congenital
Heart Surgeons Society. J Thorac Cardiovasc Surg 1997; 114: 975-987.
1008. Gandhi SK, Pigula FA, Siewers RD. Successful late reintervention after the arterial switch procedure. Ann Thorac Surg 2002; 73: 88-93.
1009. Nakanishi T, Matsumoto Y, Seguchi M, et al. Balloon angioplasty for postoperative pulmonary artery stenosis in transposition of the great arteries.
J Am Coll Cardiol 1993; 22: 859-866.
1010. Mori Y, Nakanishi T, Niki T, et al. Growth of stenotic lesions after balloon angioplasty for pulmonary artery stenosis after arterial switch operation.
Am J Cardiol 2003; 91: 693-698.
1011. Pasquali SK, Hasselblad V, Li JS, et al. Coronary artery pattern and outcome of arterial switch operation for transposition of the great arteries: a
meta-analysis. Circulation 2002; 106: 2575-2580.
1012. Kampmann C, Kuroczynski W, Trübel H, et al. Late results after PTCA for coronary stenosis after the arterial switch procedure for transposition of the
great arteries. Ann Thorac Surg 2005; 80: 1641-1646.
1013. Raisky O, Bergoend E, Agnoletti G, et al. Late coronary artery lesions after neonatal arterial switch operation: results of surgical coronary
revascularization. Eur J Cardiothorac Surg 2007; 31: 894-898.
1014. Legendre A, Chantepie A, Belli E, et al. Outcome of coronary artery bypass grafting performed in young children. J Thorac Cardiovasc Surg 2010;
139: 349-353.
1015. Rastelli GC, Wallace RB, Ongley PA. Complete repair of transposition of the great arteries with pulmonary stenosis. A review and report of a case
corrected by using a new surgical technique. Circulation 1969; 39: 83-95.
1016. Dearani JA, Danielson GK, Puga FJ, et al. Late follow-up of 1095 patients undergoing operation for complex congenital heart disease utilizing
pulmonary ventricle to pulmonary artery conduits. Ann Thorac Surg 2003; 75: 399-410.
1017. Stark J, Bull C, Stajevic M, et al. Fate of subpulmonary homograft conduits: determinants of late homograft failure. J Thorac Cardiovasc Surg 1998;
115: 506-514; discussion 514-516.
1018. Bando K, Danielson GK, Schaff HV, et al. Outcome of pulmonary and aortic homografts for right ventricular outflow tract reconstruction. J Thorac
Cardiovasc Surg 1995; 109: 509-517; discussion 517-518.
1019. Champsaur G, Robin J, Curtil A, et al. Long-term clinical and hemodynamic evaluation of porcine valved conduits implanted from the right ventricle to
the pulmonary artery. J Thorac Cardiovasc Surg 1998; 116: 793-804.
1020. Schlichter AJ, Kreutzer C, Mayorquim RC, et al. Five- to fifteen-year follow-up of fresh autologous pericardial valved conduits. J Thorac Cardiovasc
Surg 2000; 119: 869-879.
1021. Lecompte Y, Neveux JY, Leca F, et al. Reconstruction of the pulmonary outflow tract without prosthetic conduit. J Thorac Cardiovasc Surg 1982; 84:
727-733.
1022. Barbero-Marcial M, Riso A, Atik E, Jatene A. A technique for correction of truncus arteriosus types I and II without extracardiac conduits. J Thorac
Cardiovasc Surg 1990; 99: 364-369.
1023. Isomatsu Y, Shin’oka T, Aoki M, et al. Establishing right ventricle-pulmonary artery continuity by autologous tissue: an alternative approach for
prosthetic conduit repair. Ann Thorac Surg 2004; 78: 173-180.
1024. Koh M, Yagihara T, Uemura H, et al. Long-term outcome of right ventricular outflow tract reconstruction using a handmade tri-leaflet conduit. Eur J
Cardiothorac Surg 2005; 27: 807-814.
1025. Graham TP Jr, Franklin RC, Wyse RK, et al. Left ventricular wall stress and contractile function in transposition of the great arteries after the Rastelli
operation. J Thorac Cardiovasc Surg 1987; 93: 775-784.
1026. Marshall AC, Love BA, Lang P, et al. Staged repair of tetralogy of Fallot and diminutive pulmonary arteries with a fenestrated ventricular septal defect
patch. J Thorac Cardiovasc Surg 2003; 126: 1427-1433.
1027. Duncan BW, Mee RB, Prieto LR, et al. Staged repair of tetralogy of Fallot with pulmonary atresia and major aortopulmonary collateral arteries. J
Thorac Cardiovasc Surg 2003; 126: 694-702.
1028. Nakazawa M, Okuda H, Imai Y, et al. Hemodynamic response to exercise in patients 2 to 6 years after Rastelli operation. Jpn Circ J 1986; 5: 859-
862.
1029. Bermudez CA, Dearani JA, Puga FJ, et al. Late results of the peel operation for replacement of failing extracardiac conduits. Ann Thorac Surg 2004;
77: 881-887; discussion 888.
1030. Peng LF, McElhinney DB, Nugent AW, et al. Endovascular stenting of obstructed right ventricle-to-pulmonary artery conduits: a 15-year experience.
Circulation 2006; 113: 2598-2605.
1031. Vincent JA. Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US melody valve trial.
Circulation 2010; 122: 507-516.
1032. Marc Gewillig. The Fontan circulation. Heart 2005: 839-846.
1033. Dimopoulos K, Diller GP, Koltsida E, et al. Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease.
Circulation 2008; 117: 2320-2328.
1034. Baek JS, Bae EJ, Ko JS, et al. Late hepatic complications after Fontan operation; non-invasive markers of hepatic fibrosis and risk factors. Heart
2010; 96: 1750-1755.
1035. Bédard E, Lopez S, Perron J, et al. Life-threatening hemoptysis following the Fontan procedure. Can J Cardiol 2008; 24: 145-147.
1036. Vyas H, Driscoll DJ, Cetta F, et al. Gastrointestinal bleeding and protein-losing enteropathy after the fontan operation. Am J Cardiol 2006; 98: 666-
667.
1037. Egan M, Phillips A, Cook SC. Aortic dissection in the adult Fontan with aortic root enlargement. Pediatr Cardiol 2009; 30: 562-563.
1038. Ohuchi H, Miyamoto Y, Yamamoto M, et al. High prevalence of abnormal glucose metabolism in young adult patients with complex congenital heart
disease. Am Heart J 2009; 158: 30-39.
1039. Do TB, Chu JM, Berdjis F, et al. Fontan patient with plastic bronchitis treated successfully using aerosolized tissue plasminogen activator: a case
report and review of the literature. Pediatr Cardiol 2009; 30: 352-355.
1040. Valente AM, Bhatt AB, Cook S, et al. AARCC (Alliance for Adult Research in Congenital Cardiology) Investigators. The CALF (Congenital Heart
Disease in Adults Lower Extremity Systemic Venous Health in Fontan Patients) study. J Am Coll Cardiol 2010; 56: 144-150.
1041. Koh M, Uemura H, Kada A, et al. Chronologic changes in P-wave characteristics after the Fontan procedure: the effect of surgical modification. J
Thorac Cardiovasc Surg 2010; 140: 137-143.
1042. Ohuchi H, Miyazaki A, Wakisaka Y, et al. Systemic ventricular morphology-associated increased QRS duration compromises the ventricular
mechano-electrical and energetic properties long-term after the Fontan operation. Int J Cardiol 2009; 133: 371-380.
1043. Westhoff-Bleck M, Norozi K, Schoof S, et al. QRS duration in Fontan circulation in adults: a predictor of aerobic capacity. Int J Cardiol 2009; 132:
375-381.
1044. Rathod RH, Prakash A, Powell AJ, et al. Myocardial fibrosis identified by cardiac magnetic resonance late gadolinium enhancement is associated
with adverse ventricular mechanics and ventricular tachycardia late after Fontan operation. J Am Coll Cardiol 2010; 55: 1721-1728.
1045. Dimopoulos K, Diller GP, Petraco R, et al. Hyponatraemia: A strong predictor of mortality in adults with congenital heart disease. Eur Heart J 2010;
31: 595-601.
1046. Ohuchi H, Negishi J, Miyake A, et al. Long-term prognostic value of cardiac autonomic nervous activity in postoperative patients with congenital heart
disease. Int J Cardiol 2010; Jun 24. [Epub ahead of print] .
1047. Earing MG, Cetta F, Driscoll DJ, et al. Long-term results of the Fontan operation for double-inlet left ventricle. Am J Cardiol 2005; 96: 291-298.
1048. Ono M, Boethig D, Goerler H, et al. Clinical outcome of patients 20 years after Fontan operation--effect of fenestration on late morbidity. Eur J
Cardiothorac Surg 2006; 30: 923-929.
1049. Khairy P, Fernandes SM, Mayer JE Jr, et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery.
Circulation 2008; 117: 85-92.
1050. Durongpisitkul K, Porter CJ, Cetta F, et al. Predictors of early- and late-onset supraventricular tachyarrhythmias after Fontan operation. Circulation
1998; 98: 1099-1107.
1051. 中沢誠,篠原徳子,他.先天性心疾患術後不整脈の発生要因並びにその予防および管理に関する研究.厚生労働省循環器委託研究による研究報告(12C-
11).2003;60: 60-603.
1052. Wu MH, Wang JK, Lin JL, et al. Cardiac rhythm disturbances in patients with left atrial isomerism. Pacing Clin Electrophysiol 2001; 11: 1631-1638.
1053. Mavroudis C, Backer CL, Deal BJ. Late reoperations for Fontan patients: state of the art invited review. Eur J Cardiothorac Surg 2008; 34: 1034-1040.
1054. Mertens L, Hagler DJ, Sauer U, et al. Protein-losing enteropathy after the Fontan operation: an international multicenter study. PLE study group. J
Thorac Cardiovasc Surg 1998; 115: 1063-1073.
1055. Lenz D, Hambsch J, Schneider P, et al. Protein-losing enteropathy in patients with Fontan circulation: is it triggered by infection? Crit Care 2003; 7:
185-190.
1056. Bode L, Murch S, Freeze HH. Heparan sulfate plays a central role in a dynamic in vitro model of protein-losing enteropathy. J Biol Chem 2006; 281:
7809-7815.
1057. Hoashi T, Ichikawa H, Ueno T, et al. Steroid pulse therapy for protein-losing enteropathy after the Fontan operation. Congenit Heart Dis 2009; 4:
284-287.
1058. Vyas H, Driscoll DJ, Cabalka AK, et al. Results of transcatheter Fontan fenestration to treat protein losing enteropathy. Catheter Cardiovasc Interv
2007; 69: 584-589.
1059. Ryerson L, Goldberg C, Rosenthal A, et al. Usefulness of heparin therapy in protein-losing enteropathy associated with single ventricle palliation.
Am J Cardiol 2008; 101: 248-251.
1060. Tsuzuki T, Okada H, Takenaka R, et al. Reversal of proteinlosing enteropathy with heparin therapy in an adult patient with congenital heart disease.
Digestion 2006; 74: 206-207.
1061. Reinhardt Z, Uzun O, Bhole V, et al. Sildenafil in the management of the failing Fontan circulation. Cardiol Young 2010; 20: 522-525.
1062. Bernstein D, Naftel D, Chin C, et al. Pediatric Heart Transplant Study. Outcome of l i s t ing for cardiac transplantation for failed Fontan: a multi-
institutional study. Circulation 2006; 114: 273-280.
1063. Lamour JM, Kanter KR, Naftel DC, et al. Cardiac Transplant Registry Database; Pediatric Heart Transplant Study. The effect of age, diagnosis, and
previous surgery in children and adults undergoing heart transplantation for congenital heart disease. J Am Coll Cardiol 2009; 54: 160-165.
1064. Brown JW, Ruzmetov M, Vijay P, et al. Pulmonary arteriovenous malformations in children after the Kawashima operation. Ann Thorac Surg 2005;
80: 1592-1596.
1065. Kim SJ, Bae EJ, Lee JY, et al. Inclusion of hepatic venous drainage in patients with pulmonary arteriovenous fistulas. Ann Thorac Surg 2009; 87:
548-553.
1066. Nakamura Y, Yagihara T, Kagisaki K, et al. Pulmonary arteriovenous malformations after a Fontan operation in the left isomerism and absent inferior
vena cava. Eur J Cardiothorac Surg 2009; 36: 69-76.
1067. Imoto Y, Sese A, Joh K. Redirection of the hepatic venous flow for the treatment of pulmonary arteriovenous malformations after Fontan operation.
Pediatr Cardiol 2006; 27: 490-492.
1068. Kwon BS, Bae EJ, Kim GB, et al. Development of bilateral diffuse pulmonary arteriovenous fistula after Fontan procedure: is there nonhepatic factor?
Ann Thorac Surg 2009; 88: 677-680.
1069. Urcelay GE, Borzutzky AJ, Becker PA, et al. Nitric oxide in pulmonary arteriovenous malformations and Fontan procedure. Ann Thorac Surg 2005;
80: 338-340.
1070. McElhinney DB, Marshall AC, Lang P, et al. Creation of a brachial arteriovenous fistula for treatment of pulmonary ar ter iovenous mal format ions af
ter cavopulmonary anastomosis. Ann Thorac Surg 2005; 80: 1604-1609.
1071. Jacobs ML, Pourmoghadam KK. Thromboembolism and the role of anticoagulation in the Fontan patient. Pediatr Cardiol 2007; 28: 457-464.
1072. Tsang W, Johansson B, Salehian O, et al. Intracardiac thrombus in adults with the Fontan circulation. Cardiol Young 2007; 17: 646-651.
1073. Cheung YF, Chay GW, Ma ES. Ethnic differences in coagulation factor abnormalities after the Fontan procedure. Pediatr Cardiol 2006; 27: 96-101.
1074. Dehghani P, Collins N, Horlick E, et al. Chronic pulmonary thromboembolism in a patient with a fontan circulation: percutaneous management.
Catheter Cardiovasc Interv. 2007; 70: 893-836.
1075. Gaitan BD, Ramakrishna H, Dinardo JA, et al. Case 1--2010 Pulmonary thrombectomy in an adult with fontan circulation. J Cardiothorac Vasc
Anesth
2010; 24: 173-182.
1076. Senzaki H, Masutani S, Kobayashi J, et al. Ventricular afterload and ventricular work in fontan circulation: comparison with normal two-ventricle
circulation and singleventricle circulation with blalock-taussig shunts. Circulation 2002; 105: 2885-2892.
1077. Cardis BM, Fyfe DA, Mahle WT. Elastic properties of the reconstructed aorta in hypoplastic left heart syndrome. Ann Thorac Surg 2006; 81: 988-991.
1078. Jin SM, Noh CI, Bae EJ, et al. Impaired vascular function in patients with Fontan circulation. Int J Cardiol 2007; 120: 221-226.
1079. Khambadkone S, Li J, de Leval MR, et al. Basal pulmonary vascular resistance and nitric oxide responsiveness late after Fontan-type operation.
Circulation 2003; 107: 3204-3208.
1080. Ahmed A, Husain A, Love TE, et al. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using
propensity score methods. Eur Heart J 2006; 27: 1431-1439.
1081. Kouatli AA, Garcia JA, Zellers TM, et al. Enalapril does not enhance exercise capacity in patients after Fontan procedure. Circulation 1997; 96: 1507-
1512.
1082. Ishibashi N, Park IS, Takahashi Y, et al. Effectiveness of carvedilol for congestive heart failure that developed long after modified Fontan operation.
Pediatr Cardiol 2006; 27: 473-475.
1083. Ohuchi H, Watanabe K, Kishiki K, et al. Heart rate dynamics during and after exercise in postoperative congenital heart disease patients. Their
relation to cardiac autonomic nervous activity and intrinsic sinus node dysfunction. Am Heart J 2007; 154: 165-171.
1084. Higaki T, Kondo C, Tomimatsu H, et al. Asynchronous contraction of the 2 ventricles caused by ventricular pacing after a Fontan-type operation in a
patient with a biventricular heart. Int J Cardiol 2010 Mar 10. [Epub ahead of print].
1085. Mavroudis C, Stewart RD, Backer CL, et al Atrioventricular valve procedures with repeat fontan operations: influence of valve pathology, ventricular
function, and arrhythmias on outcome. Ann Thorac Surg 2005; 80: 29-36.
1086. Ronco C, McCullough P, Anker SD, et al. Acute Dialysis Quality Initiative (ADQI) consensus group. Cardio-renal syndromes: report from the
consensus conference of the acute dialysis quality initiative. Eur Heart J 2010; 31: 703-711.
1087. Sammour F, Haw M, Paisey J, et al. Renal function of patients with a failing Fontan circuit undergoing total cavopulmonary revision surgery. Pediatr
Cardiol 2009; 30: 282-288.
1088. Anne P, Du W, Mattoo TK, et al. Nephropathy in patients after Fontan palliation. Int J Cardiol 2009; 132: 244-247.
1089. Marcelletti CF, Hanley FL, Mavroudis C, et al. Revision of previous Fontan connect ions to total ext racardiac cavopulmonary anastomosis:
A multicenter experience.J Thorac Cardiovasc Surg 2000; 119: 340-346.
1090. Momma K, Kondoh C, Matsuoka R. Tetralogy of Fallot with pulmonary atresia associated with chromosome 22q11 deletion. J Am Coll Cardiol 1996;
27: 198-202.
1091. Rossi RN, Hislop A, Anderson RH, et al. Systemic-topulmonary artery blood supply in tetralogy of Fallot with pulmonary atresia. Cardiol Young 2002;
12: 373-388.
1092. Betranou EG, Blackstone EH, Hazeltrig JB, et al. life expectancy without surgery in tetralogy of Fallot. Am J Cardiol 1978; 42: 458-466.
1093. Cho JM, Puga FJ, Danielson GK, et al. Early and long-term results of the surgical treatment of tetralogy of Fallot with pulmonary atresia, with or
without major aortopulmonary collaterals. J Thorac Cardiovasc Surg 2002; 124: 70-81.
1094. Momma K. Cardiovascular anomalies associated with chromosome 22q11.2 deletion syndrome. Am J Cardiol 2010; 105: 1617-1624.
1095. Maeda J, Yamagishi H, Matsuoka R, et al. Frequent association of 22q11.2 deletion with tetralogy of Fallot. Am J Med Genet 2000; 92: 269-272.
1096. Perloff JK. The Univentricular Heart. In “Clinical Recognition of Congenital Heart Disease (5th ed)” Perloff JK, ed. WB Saunders, Philadelphia
2003: 498-516.
1097. Gatzoulis MA, Munk MD, Williams WG, et al. Definitive palliation with cardiopulmonary or aortopulmonary shunts for adults with single ventricle
physiology. Heart 2000; 83; 51-57.
1098. Ammash NM, Warnes CA. Survival into adulthood of patients with unoperated single ventricle. Am J Cardiol 1996; 77: 543-544.
1099. Moodie DS, Ritter DG, Tajik AJ, et al. Long-term followup after palliative operation for univentricular heart. Am J Cardiol 1984; 53: 1648-1651.
1100. 丹羽公一郎.肺血流減少性チアノーゼ型先天性心疾患.新目で見る循環器病シリーズ14 成人先天性心疾患(丹羽公一郎,中澤誠編著).メジカルビュー社
2005:380-387.
1101. Srivastava D, Preminger T, Lock JE, et al. Hepatic venous blood and the development of pulmonary arteriovenous malformations in congenital heart
disease. Circulation 1995; 92: 1217-1222. 135